Table 1 Baseline patient characteristics in the health-related quality of life substudy population
Characteristics | Ticargrelor (N = 56) | Clopidogrel (N = 57) |
|---|---|---|
Female sex, N (%) | 8 (14.3%) | 11 (19.3%) |
Age, years | 57.9 ± 12.4 | 58.1 ± 11.3 |
Body mass index, kg/m2 | 25.2 ± 3.8 | 24.9 ± 2.9 |
Risk factors | Â | Â |
 Diabetes mellitus, N (%) | 21 (37.5%) | 20 (35.1%) |
 Hypertension, N (%) | 24 (42.8%) | 25 (43.9%) |
 Dyslipidemia, N (%) | 17 (30.4%) | 16 (28.1%) |
 Current smoker, N (%) | 33 (58.9%) | 25 (43.9%) |
Ejection fraction, % | 52.1 ± 9.0 | 52.2 ± 9.7 |
Clinical presentation | Â | Â |
 Unstable angina, N (%) | 13 (23.2%) | 16 (28.1%) |
 NSTEMI, N (%) | 26 (46.4%) | 22 (38.6%) |
 STEMI, N (%) | 17 (30.4%) | 19 (33.3%) |
Discharge medication | Â | Â |
 Beta-blocker, N (%) | 54 (96.4%) | 52 (91.2%) |
 ACE inhibitor or ARB, N (%) | 49 (87.5%) | 48 (84.2%) |
 Statin, N (%) | 56 (100.0%) | 57 (100.0%) |
 Aspirin, N (%) | 56 (100.0%) | 57 (100.0%) |
Cardiac rehabilitation, N (%) | 51 (91.1%) | 50 (89.3%) |
Number of vessels diseased | Â | Â |
 1 vessel disease, N (%) | 38 (67.8%) | 36 (63.1%) |
 2 vessel disease, N (%) | 15 (26.8%) | 18 (31.6%) |
 3 vessel disease, N (%) | 3 (5.4%) | 3 (5.3%) |
GRACE score | 109 ± 21 | 110 ± 18 |
Laboratory findings | Â | Â |
 Serum hemoglobin, g/dl | 14.4 ± 1.8 | 14.1 ± 1.3 |
 Platelet count, × 109/L | 24.54 ± 5.5 | 23.70 ± 7.4 |
 Serum creatinine, mg/dL | 1.0 ± 0.3 | 1.0 ± 0.2 |
 Cardiac troponin I, ng/mL | 48.0 ± 60.7 | 49.4 ± 68.8 |
 Brain natriuretic peptide, pg/mL | 60.2 ± 100.1 | 73.1 ± 93.6 |
 LDL cholesterol, mg/dL | 120.9 ± 36.2 | 119.0 ± 33.8 |
 HDL cholesterol, mg/dL | 42.9 ± 9.8 | 44.9 ± 12.5 |
 Total cholesterol, mg/dL | 187.6 ± 47.4 | 194.6 ± 47.7 |
 Triglycerides, mg/dL | 174.4 ± 130.3 | 170.1 ± 104.4 |